Evidence map›Paper›PMID 30405846›Full record

ArticleJournal of Cancer2018

Paired box 2 promotes progression of endometrial cancer via regulating cell cycle pathway.

Jieyu Wang, Nan Jia, Tianjiao Lyv, Chao Wang, Xiang Tao, KwongKwok Wong, Qin Li, Weiwei Feng

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Near-Infrared Fluorescent Agent forFrontiers in oncology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jieyu WangDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200032, China.
Nan JiaDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200032, China.
Tianjiao LyvDepartment of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Chao WangDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200032, China.
Xiang TaoDepartment of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
KwongKwok WongDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Qin LiDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200032, China.
Weiwei FengDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200032, China.
Obstetrics and Gynecology Hospital of Fudan University · CNFudan University · CNRuijin Hospital · CNThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell proliferationOvarian cancerPAX2

Identifiers

PMID30405846
PMCPMC6216001
OpenAlexW2898261907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.